<i>Saccharomyces boulardii</i>for prevention of necrotizing enterocolitis in preterm infants: a randomized, controlled study
Gamze Demırel, Ömer Erdeve, İstemi Han Çelik, Uğur Dilmen
Acta Paediatrica
Abstract
Although Saccharomyces boulardii supplementation at a dose of 250 mg/day was not effective at reducing the incidence of death or NEC in VLBW infants, it improved feeding tolerance and reduced the risk of clinical sepsis.
Extracted Claims
2 claims extracted from this paper into the knowledge graph
Saccharomyces boulardii reduced risk of clinical sepsis
“Although Saccharomyces boulardii supplementation at a dose of 250 mg/day was not effective at reducing the incidence of death or NEC in VLBW infants, it improved feeding tolerance and reduced the risk...”
Saccharomyces boulardii improved feeding tolerance
“Although Saccharomyces boulardii supplementation at a dose of 250 mg/day was not effective at reducing the incidence of death or NEC in VLBW infants, it improved feeding tolerance and reduced the risk...”